Hepatitis C dilemma?
نویسندگان
چکیده
منابع مشابه
Hepatitis C virus and skin
Nowadays viral hepatitis is one of the most common and important causes of chronic liver disorders in the world. Extrahepatic manifestations of viral hepatitis consist a main part of the disease. The main viruses causing hepatitis include Hepatitis A, B and C viruses. Herein common skin manifestations in hepatitis C virus (HCV) are discussed. Chronic hepatitis causes skin disorders both directl...
متن کاملSeroprevalence of Hepatitis B, Hepatitis C and Human
Abstract Background Thalassemia patients that are conventionally treated by a regular transfusion regimen are exposed to blood born viral infections.The aim of this study was to investigate the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) , and human Immunodeficiency virus(HIV) among all multitransfused thalassemia patients in west north of Iran. Material and methods A...
متن کاملHepatitis B: A Current Global Health Dilemma
v Hepatitis B virus (HBV) infection causes a spectrum of acute and chronic liver disease, with chronic infection ranging from inactive carrier status to progressive chronic hepatitis, culminating in end-stage cirrhosis and liver cancer. Over one-third of the world’s population has been or is currently infected with HBV and 350 to 400 million people remain chronic hepatitis B surface antigen (HB...
متن کاملImmune tolerant hepatitis B: a clinical dilemma.
Chronic hepatitis B virus infection remains a global health concern, with perinatal transmission still a problem in many countries. Several new therapies for chronic hepatitis B virus infection have recently been introduced that can safely and effectively suppress viral replication with a low risk of resistance; thus, it has become increasingly tempting for many clinicians to treat patients in ...
متن کاملHepatitis C Virus and Vaccine Development
The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Liver Transplantation and Surgery
سال: 1996
ISSN: 1074-3022
DOI: 10.1002/lt.500020111